Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
MedTravest A/S
A/S
Active
CVR 38292412
Vestergade 48, 8600
Silkeborg
Activities of holding companies
·
NACE 6421
Est. 2016 · 9 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
MedTravest A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
BS
Bernt Skov Jensen
Management
Management
2016 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
TJ
Tore Jesper Andersen
Board of Directors
Board of Directors
2023
ML
Mark Lund Andersen
Chairman
Chairman
2023
JS
Jens Strathe
Board of Directors
Board of Directors
2025
Former (3)
PJ
Peter Juul Kristensen
Chairman
Chairman
2016 – 2023
BS
Bernt Skov Jensen
Board of Directors
Board of Directors
2016 – 2023
KT
Kresten Tranberg Johansen
Shareholders
As of last annual report
L. O. JENSEN HOLDING ApS — 10–14.99%
STRATHE INVEST ApS — 10–14.99%
Tore Jesper Andersen — 10–14.99%
JUUL KRISTENSEN HOLDING ApS — 10–14.99%
WIIK INVEST ApS — 10–14.99%
MLU Holding af 10/1-2017 ApS — 10–14.99%
LBF Invest ApS — 5–9.99%
Jannie Dahl — 5–9.99%
SCANSYS HOLDING ApS — 10–14.99%
Kresten Tranberg Johansen — 5–9.99%
Lars Bo Fredsted — 5–9.99%
90–100%
Shareholder
Type
Ownership
Votes
Since
L. O. JENSEN HOLDING ApS
Company
10–14.99%
10–14.99%
2016
STRATHE INVEST ApS
Company
10–14.99%
10–14.99%
2017
Tore Jesper Andersen
Individual
10–14.99%
10–14.99%
2017
JUUL KRISTENSEN HOLDING ApS
Company
10–14.99%
10–14.99%
2017
WIIK INVEST ApS
Company
10–14.99%
10–14.99%
2016
MLU Holding af 10/1-2017 ApS
Company
10–14.99%
10–14.99%
2017
LBF Invest ApS
Company
5–9.99%
5–9.99%
2020
Jannie Dahl
Individual
5–9.99%
5–9.99%
2017
SCANSYS HOLDING ApS
Company
10–14.99%
5–9.99%
2016
Kresten Tranberg Johansen
Individual
5–9.99%
0%
2017
Lars Bo Fredsted
Individual
5–9.99%
5–9.99%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on MedTravest A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Board of Directors
Board of Directors
2023 – 2025